These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23991195)

  • 1. Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling.
    Yong R; Chen XM; Shen S; Vijayaraj S; Ma Q; Pollock CA; Saad S
    PLoS One; 2013; 8(8):e73428. PubMed ID: 23991195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming Growth Factor β1-Induced NADPH Oxidase-4 Expression and Fibrotic Response in Conjunctival Fibroblasts.
    Brown KD; Shah MH; Liu GS; Chan EC; Crowston JG; Peshavariya HM
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3011-3017. PubMed ID: 28605812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
    Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
    Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
    Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
    Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.
    Gorin Y; Block K; Hernandez J; Bhandari B; Wagner B; Barnes JL; Abboud HE
    J Biol Chem; 2005 Nov; 280(47):39616-26. PubMed ID: 16135519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
    He T; Xiong J; Nie L; Yu Y; Guan X; Xu X; Xiao T; Yang K; Liu L; Zhang D; Huang Y; Zhang J; Wang J; Sharma K; Zhao J
    J Mol Med (Berl); 2016 Dec; 94(12):1359-1371. PubMed ID: 27488452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48-linked NADPH oxidase 4 polyubiquitination and degradation.
    Chen Z; Sun X; Chen Q; Lan T; Huang K; Xiao H; Lin Z; Yang Y; Liu P; Huang H
    Br J Pharmacol; 2020 Jan; 177(1):145-160. PubMed ID: 31465542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
    Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
    Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
    Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy.
    De Blasio MJ; Ramalingam A; Cao AH; Prakoso D; Ye JM; Pickering R; Watson AMD; de Haan JB; Kaye DM; Ritchie RH
    Eur J Pharmacol; 2017 Jul; 807():12-20. PubMed ID: 28438648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.
    Ford BM; Eid AA; Göőz M; Barnes JL; Gorin YC; Abboud HE
    Am J Physiol Renal Physiol; 2013 Aug; 305(3):F323-32. PubMed ID: 23678045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
    Shi Q; Lee DY; Féliers D; Abboud HE; Bhat MA; Gorin Y
    Mol Metab; 2020 Jun; 36():100968. PubMed ID: 32240965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
    Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor Beta 1 Drives a Switch in Connexin Mediated Cell-to-Cell Communication in Tubular Cells of the Diabetic Kidney.
    Hills C; Price GW; Wall MJ; Kaufmann TJ; Chi-Wai Tang S; Yiu WH; Squires PE
    Cell Physiol Biochem; 2018; 45(6):2369-2388. PubMed ID: 29587265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated albumin triggers fibrosis and apoptosis via an NADPH oxidase/Nox4-MAPK pathway-dependent mechanism in renal proximal tubular cells.
    Qi W; Niu J; Qin Q; Qiao Z; Gu Y
    Mol Cell Endocrinol; 2015 Apr; 405():74-83. PubMed ID: 25681565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
    Cha JJ; Min HS; Kim KT; Kim JE; Ghee JY; Kim HW; Lee JE; Han JY; Lee G; Ha HJ; Bae YS; Lee SR; Moon SH; Lee SC; Kim G; Kang YS; Cha DR
    Lab Invest; 2017 Apr; 97(4):419-431. PubMed ID: 28165467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.